CSL Limited (CSL.AX) Dividend Yield, History & Forecast

CSL Limited (CSL.AX) is a Biotechnology company in the Healthcare sector listed on the Australian Securities Exchange. It pays a current dividend yield of 3.71% ($2.94 per share annually (TTM)). The trailing twelve-month payout ratio is 103.1%; the market capitalization is approximately $55.01B.

Loading quote...

Frequently Asked Questions about CSL Limited (CSL.AX)

What is CSL Limited's dividend yield?
CSL Limited (CSL.AX) pays a current trailing twelve-month dividend yield of 3.71%, which works out to $2.94 per share annually based on the most recent payout schedule.
Is CSL Limited a Dividend Aristocrat?
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is CSL Limited in?
CSL Limited (CSL.AX) operates in the Healthcare sector, specifically the Biotechnology industry.
What is CSL Limited's dividend payout ratio?
CSL Limited (CSL.AX)'s trailing twelve-month dividend payout ratio is 103.1%. The payout ratio measures what percentage of earnings is paid out as dividends — a lower ratio generally suggests a more sustainable dividend.
CSL Limited (CSL.AX) Dividend Yield, History & Forecast | Dividend Wealth